As of Sep 7, 2024, Organo's P/S ratio stood at 2.7, a 110.94% change from the 1.28 P/S ratio recorded in the previous year.

The Organo P/S history

Organo Aktienanalyse

What does Organo do?

Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation." Organo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Organo's P/S Ratio

Organo's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Organo's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Organo's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Organo’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Organo stock

What is the price-to-earnings ratio of Organo?

The price-earnings ratio of Organo is currently 2.7.

How has the price-earnings ratio of Organo changed compared to last year?

The price-to-earnings ratio of Organo has increased by 110.94% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Organo high compared to other companies?

Yes, the price-to-earnings ratio of Organo is high compared to other companies.

How does an increase in the price-earnings ratio of Organo affect the company?

An increase in the price-earnings ratio of Organo would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Organo affect the company?

A decrease in the price-earnings ratio of Organo would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Organo?

Some factors that influence the price-earnings ratio of Organo are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Organo pay?

Over the past 12 months, Organo paid a dividend of 114 JPY . This corresponds to a dividend yield of about 1.85 %. For the coming 12 months, Organo is expected to pay a dividend of 118.51 JPY.

What is the dividend yield of Organo?

The current dividend yield of Organo is 1.85 %.

When does Organo pay dividends?

Organo pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Organo?

Organo paid dividends every year for the past 23 years.

What is the dividend of Organo?

For the upcoming 12 months, dividends amounting to 118.51 JPY are expected. This corresponds to a dividend yield of 1.92 %.

In which sector is Organo located?

Organo is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Organo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Organo from 12/1/2024 amounting to 53 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Organo pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Organo in the year 2023?

In the year 2023, Organo distributed 74 JPY as dividends.

In which currency does Organo pay out the dividend?

The dividends of Organo are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Organo

Our stock analysis for Organo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.